Xiao-hong Li

Changsha, 410011, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Lactylation in pulmonary fibrosis: current understanding and challenges.

Lactylation in pulmonary fibrosis: current understanding and challenges.

Journal: Journal of translational medicine
Published: November 30, 2025

A case report: identifying a novel variant in ELOC(TCEB1)-mutant renal cell carcinoma.

A case report: identifying a novel variant in ELOC(TCEB1)-mutant renal cell carcinoma.

Journal: Frontiers in oncology
Published: July 08, 2025

Targeting cu metabolism as a potential therapeutic strategy for pulmonary fibrosis.

Targeting cu metabolism as a potential therapeutic strategy for pulmonary fibrosis.

Journal: Biochimica et biophysica acta. Reviews on cancer
Published: April 04, 2025

Histone deacetylases: potential therapeutic targets for idiopathic pulmonary fibrosis.

Histone deacetylases: potential therapeutic targets for idiopathic pulmonary fibrosis.

Journal: Frontiers in cell and developmental biology
Published: May 01, 2024

DNA methylation modification in Idiopathic pulmonary fibrosis.

DNA methylation modification in Idiopathic pulmonary fibrosis.

Journal: Frontiers in cell and developmental biology
Published: April 12, 2024

Corrigendum to "NMDA receptor activation induces damage of alveolar type II cells and lung fibrogenesis through ferroptosis" [Biochim. Biophys. Acta, Mol. Cell Res. 2023 Oct; 1870(7): 119535].

Corrigendum to "NMDA receptor activation induces damage of alveolar type II cells and lung fibrogenesis through ferroptosis" [Biochim. Biophys. Acta, Mol. Cell Res. 2023 Oct; 1870(7): 119535].

Journal: Biochimica et biophysica acta. Molecular cell research
Published: September 26, 2023

NMDA receptor activation induces damage of alveolar type II cells and lung fibrogenesis through ferroptosis.

NMDA receptor activation induces damage of alveolar type II cells and lung fibrogenesis through ferroptosis.

Journal: Biochimica et biophysica acta. Molecular cell research
Published: March 11, 2023

Case Report: An NTRK1 fusion-positive embryonal rhabdomyosarcoma: clinical presentations, pathological characteristics and genotypic analyses.

Case Report: An NTRK1 fusion-positive embryonal rhabdomyosarcoma: clinical presentations, pathological characteristics and genotypic analyses.

Journal: Frontiers in oncology
Published: March 03, 2023

NMDAR activation attenuates the protective effect of BM-MSCs on bleomycin-induced ALI via the COX-2/PGE2 pathway.

NMDAR activation attenuates the protective effect of BM-MSCs on bleomycin-induced ALI via the COX-2/PGE2 pathway.

Journal: Heliyon
Published: February 01, 2023

Sp1 mediated the inhibitory effect of glutamate on pulmonary surfactant synthesis.

Sp1 mediated the inhibitory effect of glutamate on pulmonary surfactant synthesis.

Journal: PloS one
Published: December 19, 2022

N-methyl-D-aspartate receptor blockers attenuate bleomycin-induced pulmonary fibrosis by inhibiting endogenous mesenchymal stem cells senescence.

N-methyl-D-aspartate receptor blockers attenuate bleomycin-induced pulmonary fibrosis by inhibiting endogenous mesenchymal stem cells senescence.

Journal: Annals of translational medicine
Published: April 24, 2022

Research progress of endogenous bone marrow-derived mesenchymal stem cells in pulmonary fibrosis

Research progress of endogenous bone marrow-derived mesenchymal stem cells in pulmonary fibrosis

Journal: Sheng li xue bao : [Acta physiologica Sinica]
Published: October 27, 2020
Showing 1-12 of 15

Last Updated: 09/26/2026